Reconstituting BPC-157 correctly is the difference between dosing 250 mcg and dosing 500 mcg on the same syringe mark — the math depends entirely on the vial size and the bacteriostatic water volume you added. This page walks through the exact numbers for BPC-157's two common vial sizes (5 mg and 10 mg) and includes a dose-to-syringe-unit reference table plus a free calculator pre-filled with a typical BPC-157 protocol.
Key Takeaways
- —BPC-157 is typically supplied in 5 mg or 10 mg lyophilised vials. 2 mL of bacteriostatic water is the standard diluent for both.
- —Standard concentrations after reconstitution: 2,500 mcg/mL (5 mg vial) or 5,000 mcg/mL (10 mg vial).
- —The common 250 mcg BPC-157 dose = 10 units on a U-100 insulin syringe (5 mg vial reconstituted with 2 mL BAC water).
- —A 5 mg vial yields 20 doses at 250 mcg each; a 10 mg vial yields 40. A typical 6-week cycle at 250 mcg × 2 daily needs 2 × 5 mg vials or 1 × 10 mg vial.
- —Reconstituted solution stores 28 days at 2–8°C (Next Pep BPC-157 profile).
| Vial Size | BAC Water | Concentration | Notes |
|---|---|---|---|
| 5 mg | 2 mL | 2,500 mcg/mL | Most common; 10 units = 250 mcg |
| 5 mg | 1 mL | 5,000 mcg/mL | Double concentration; 5 units = 250 mcg |
| 10 mg | 2 mL | 5,000 mcg/mL | Most common for 10 mg vials |
| 10 mg | 4 mL | 2,500 mcg/mL | Matches 5 mg / 2 mL draw volumes |
The 5 mg vial + 2 mL reconstitution is the default most research protocols reference because it produces convenient syringe marks for the 200–500 mcg range.
Assuming a U-100 insulin syringe (100 units = 1 mL). All numbers below are for the standard 2,500 mcg/mL concentration (5 mg vial + 2 mL BAC water):
| Target Dose | Draw Volume | U-100 Units |
|---|---|---|
| 100 mcg | 0.04 mL | 4 units |
| 150 mcg | 0.06 mL | 6 units |
| 200 mcg | 0.08 mL | 8 units |
| 250 mcg | 0.10 mL | 10 units |
| 300 mcg | 0.12 mL | 12 units |
| 400 mcg | 0.16 mL | 16 units |
| 500 mcg | 0.20 mL | 20 units |
For the double-concentration 5,000 mcg/mL variant (10 mg + 2 mL, or 5 mg + 1 mL), halve the unit count: 250 mcg = 5 units, 500 mcg = 10 units.
The formula is simple: total cycle mg = daily dose mcg × doses per day × cycle length in days ÷ 1,000.
Common BPC-157 protocols translated to vial counts:
| Protocol | Total Dose | 5 mg vials | 10 mg vials |
|---|---|---|---|
| 250 mcg × 1/day × 4 weeks | ~7 mg | 2 | 1 |
| 250 mcg × 2/day × 6 weeks | ~21 mg | 5 | 3 |
| 500 mcg × 2/day × 8 weeks | ~56 mg | 12 | 6 |
Always round up when ordering — lyophilised vials keep for years at –20°C, so extra inventory is not wasted, but running short mid-cycle requires a repeat order and a reconstitution-date reset on the new vial.
The dosing calculator at /dosing-calculator has deep-link support — the link above opens the calculator with BPC-157's most common protocol already entered (5 mg vial, 2 mL BAC water, 250 mcg target dose). It shows you the draw volume in mL and the insulin-syringe unit count in real time as you adjust any input.
No signup. Browser-based. Works on mobile.
Three BPC-157-specific reconstitution mistakes we see in practitioner reports:
For the typical 5 mg vial reconstituted with 2 mL of bacteriostatic water (2,500 mcg/mL concentration): 250 mcg = 10 units, 500 mcg = 20 units on a U-100 insulin syringe. Always recalculate if you switch to a different vial size or diluent volume.
2 mL is the standard research-protocol default — yields 2,500 mcg/mL and produces convenient syringe marks for 200–500 mcg doses. 1 mL doubles the concentration to 5,000 mcg/mL; some protocols prefer it to reduce injection volume, but small-volume draws become harder to measure accurately.
No. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative — without it, any multi-dose vial will contaminate within 24–72 hours of reconstitution. Single-use preparations can use sterile saline but are wasteful for a 5 mg vial that typically yields 20 doses.
28 days refrigerated at 2–8 °C. Never freeze reconstituted solution — freeze-thaw cycles break the peptide structure. Label the vial with the reconstitution date on first puncture; dispose after 28 days regardless of visual appearance.
No formal upper-bound dose has been established in human trials — a 2025 IV safety study administered up to 20 mg without adverse events in two volunteers. Typical practitioner protocols stay in the 250–500 mcg range per injection, with total daily doses up to 1 mg split across multiple sites. See the BPC-157 research guide for full evidence context.
This article is for research and informational purposes only. BPC-157 is not FDA-approved for human clinical use. Consult a licensed healthcare professional before considering any peptide protocol.
Research Disclaimer. All content on Next Pep is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare professional before considering any peptide protocol.
Peptide reconstitution errors are the most common dosing mistake. Free calculator covering insulin syringe units, BAC water volumes, and vial concentration math.
Most peptide comparison content is vendor marketing. A mechanism-first framework for comparing any two peptides on data that actually predicts outcomes — plus a free tool.